Here's Why We're Not Too Worried About PharmAust's (ASX:PAA) Cash Burn Situation
Apr 09
Australian (ASX) Pharma Industry Analysis
UpdatedMay 02, 2024
DataAggregated Company Financials
Companies30
- 7D3.0%
- 3M-2.5%
- 1Y33.8%
- YTDn/a
Last week, the Pharma industry hasn't moved much but Clarity Pharmaceuticals is up 16% in that time. As for the the longer term, the industry is up 31% over the past 12 months. As for the next few years, earnings are expected to grow by 28% per annum.
Industry Valuation and Performance
Has the Australian Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 02 May 2024 | AU$5.6b | AU$1.2b | -AU$374,923,684.00 | 14.1x | -15.1x | 4.6x |
| Sat, 30 Mar 2024 | AU$6.0b | AU$1.2b | -AU$374,923,684.00 | 15x | -15.9x | 4.9x |
| Mon, 26 Feb 2024 | AU$5.4b | AU$899.7m | -AU$525,000,271.00 | 20.6x | -10.3x | 6x |
| Wed, 24 Jan 2024 | AU$5.6b | AU$896.3m | -AU$589,604,392.00 | 21x | -9.5x | 6.3x |
| Fri, 22 Dec 2023 | AU$5.4b | AU$896.3m | -AU$589,604,392.00 | 18.6x | -9.2x | 6.1x |
| Sun, 19 Nov 2023 | AU$4.1b | AU$893.0m | -AU$595,020,018.00 | 17.9x | -6.8x | 4.6x |
| Tue, 17 Oct 2023 | AU$3.5b | AU$900.3m | -AU$587,952,018.00 | 19.8x | -5.9x | 3.9x |
| Thu, 14 Sep 2023 | AU$3.7b | AU$900.3m | -AU$587,952,018.00 | 19.3x | -6.3x | 4.1x |
| Sat, 12 Aug 2023 | AU$4.0b | AU$999.0m | -AU$624,794,303.00 | 20.7x | -6.5x | 4x |
| Mon, 10 Jul 2023 | AU$4.0b | AU$999.0m | -AU$624,794,303.00 | 24.5x | -6.5x | 4x |
| Wed, 07 Jun 2023 | AU$4.0b | AU$999.0m | -AU$624,794,303.00 | 18.7x | -6.4x | 4x |
| Fri, 05 May 2023 | AU$4.1b | AU$993.2m | -AU$641,969,868.00 | 19.9x | -6.4x | 4.2x |
| Sun, 02 Apr 2023 | AU$4.2b | AU$995.9m | -AU$648,651,745.00 | 18.3x | -6.4x | 4.2x |
| Tue, 28 Feb 2023 | AU$3.6b | AU$1.0b | -AU$599,711,790.00 | 16.1x | -5.9x | 3.4x |
| Thu, 26 Jan 2023 | AU$3.9b | AU$951.8m | -AU$584,038,383.00 | 17.2x | -6.7x | 4.1x |
| Sat, 24 Dec 2022 | AU$3.9b | AU$948.3m | -AU$544,428,006.00 | 13.2x | -7.2x | 4.1x |
| Mon, 21 Nov 2022 | AU$4.4b | AU$948.3m | -AU$544,428,005.00 | 12.9x | -8x | 4.6x |
| Wed, 19 Oct 2022 | AU$4.4b | AU$946.2m | -AU$548,400,005.00 | 12x | -8x | 4.6x |
| Fri, 16 Sep 2022 | AU$4.3b | AU$943.4m | -AU$537,548,829.00 | 12.5x | -7.9x | 4.5x |
| Sun, 14 Aug 2022 | AU$4.1b | AU$819.9m | -AU$337,428,683.00 | 15.1x | -12.2x | 5x |
| Tue, 12 Jul 2022 | AU$3.4b | AU$818.2m | -AU$353,932,589.00 | 14.3x | -9.7x | 4.2x |
| Thu, 09 Jun 2022 | AU$3.7b | AU$818.2m | -AU$353,932,589.00 | 14.8x | -10.5x | 4.6x |
| Sat, 07 May 2022 | AU$3.9b | AU$800.9m | -AU$348,637,558.00 | 14.5x | -11.2x | 4.9x |
| Mon, 04 Apr 2022 | AU$4.2b | AU$799.2m | -AU$341,805,125.00 | 18.3x | -12.3x | 5.3x |
| Wed, 02 Mar 2022 | AU$4.4b | AU$788.2m | -AU$339,352,226.00 | 19.3x | -12.9x | 5.6x |
| Fri, 28 Jan 2022 | AU$4.2b | AU$758.4m | -AU$450,516,414.00 | 19.5x | -9.4x | 5.6x |
| Sun, 26 Dec 2021 | AU$4.9b | AU$758.4m | -AU$450,516,414.00 | 23.9x | -10.8x | 6.4x |
| Tue, 23 Nov 2021 | AU$4.7b | AU$758.4m | -AU$447,307,205.00 | 23.1x | -10.6x | 6.3x |
| Thu, 21 Oct 2021 | AU$4.8b | AU$753.7m | -AU$446,982,450.00 | 24.3x | -10.7x | 6.3x |
| Sat, 18 Sep 2021 | AU$4.8b | AU$753.9m | -AU$445,060,581.00 | 21.8x | -10.9x | 6.4x |
| Mon, 16 Aug 2021 | AU$4.2b | AU$752.8m | -AU$442,004,016.00 | 21x | -9.5x | 5.6x |
| Mon, 31 May 2021 | AU$4.5b | AU$758.8m | -AU$452,149,714.00 | 12.7x | -9.9x | 5.9x |
Price to Earnings Ratio
-10.6x
Current Industry PE
- Investors are relatively neutral on the Australian Pharmaceuticals industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PS ratio of 5.0x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have improved over the last three years.
- Revenues for these companies have grown 17% per year.
- This means that more sales are being generated by these companies overall, and subsequently losses are decreasing too.
Industry Comparison
How does Australian Pharma compare with similar industries?
| AU Market | -1.54% | |
| Healthcare | -1.12% | |
| Pharma | 2.98% | |
| Pharma | 2.98% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| CU6 Clarity Pharmaceuticals | AU$3.01 | 15.8% +AU$138.4m | 301.3% | PS98.6x | |
| BOT Botanix Pharmaceuticals | AU$0.23 | 9.3% +AU$31.5m | 179.8% | PS846.6x | |
| NEU Neuren Pharmaceuticals | AU$19.06 | 1.1% +AU$26.8m | 34.7% | PE15.5x | |
| VIT Vitura Health | AU$0.13 | 23.8% +AU$14.4m | -65.8% | PE8x | |
| PER Percheron Therapeutics | AU$0.073 | 14.1% +AU$8.1m | 0% | PS28.8x |
